Accelerate the shift to Synthetics
We are improving wound care for patients, health care professionals (HCPs), and society through the use of innovative polylactide technology.
An industry pioneer
PolyMedics Innovations (PMI) was founded to develop, produce, and commercialise innovative biomaterials and systems for wound treatment …

A quicker return to normality
Clinically proven effective pain relief, fast wound healing, and significant improvement in treatment outcomes for thousands of patients …

Worldwide presence
With distribution in over 40 countries, come join us at medical meetings around the world …

The proven synthetic skin substitute technology
0
0
0
RCTs
0
Cohort
0
case series/
case report
Note: Relevant Trials: Trials that are used to substantiate the claims according to the PRISMA analysis. RCTs: Randomised controlled trials. Cohort: Non-randomised, controlled studies.
— V1 February 2025 —